These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 14963200)

  • 21. The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study.
    Flendrie M; Creemers MC; Welsing PM; van Riel PL
    Rheumatology (Oxford); 2005 Apr; 44(4):472-8. PubMed ID: 15598707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.
    Kremer J; Genovese M; Cannon GW; Caldwell J; Cush J; Furst DE; Luggen M; Keystone E; Bathon J; Kavanaugh A; Ruderman E; Coleman P; Curtis D; Kopp E; Kantor S; Weisman M; Waltuck J; Lindsley HB; Markenson J; Crawford B; Fernando I; Simpson K; Strand V
    J Rheumatol; 2004 Aug; 31(8):1521-31. PubMed ID: 15290730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial.
    Stone JH; Holbrook JT; Marriott MA; Tibbs AK; Sejismundo LP; Min YI; Specks U; Merkel PA; Spiera R; Davis JC; St Clair EW; McCune WJ; Ytterberg SR; Allen NB; Hoffman GS;
    Arthritis Rheum; 2006 May; 54(5):1608-18. PubMed ID: 16646004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of leflunomide monotherapy in rheumatoid arthritis: towards the goals of disease modifying antirheumatic drug therapy.
    Smolen JS; Emery P; Kalden JR; Van Riel PL; Dougados M; Strand CV; Breedveld FC
    J Rheumatol Suppl; 2004 Jun; 71():13-20. PubMed ID: 15170903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades.
    Holle JU; Gross WL; Latza U; Nölle B; Ambrosch P; Heller M; Fertmann R; Reinhold-Keller E
    Arthritis Rheum; 2011 Jan; 63(1):257-66. PubMed ID: 20862686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations.
    Holle JU; Dubrau C; Herlyn K; Heller M; Ambrosch P; Noelle B; Reinhold-Keller E; Gross WL
    Ann Rheum Dis; 2012 Mar; 71(3):327-33. PubMed ID: 22021864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis.
    Solans-Laqué R; Bosch-Gil J; Canela M; Lorente J; Pallisa E; Vilardell-Tarrés M
    Lupus; 2008 Sep; 17(9):832-6. PubMed ID: 18755865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of leflunomide and predisposing factors for treatment response in patients with active rheumatoid arthritis: RELIEF 6-month data.
    Dougados M; Emery P; Lemmel EM; de la Serna R; Zerbini CA; Brin S; van Riel P
    J Rheumatol; 2003 Dec; 30(12):2572-9. PubMed ID: 14719196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
    Seo P; Min YI; Holbrook JT; Hoffman GS; Merkel PA; Spiera R; Davis JC; Ytterberg SR; St Clair EW; McCune WJ; Specks U; Allen NB; Luqmani RA; Stone JH;
    Arthritis Rheum; 2005 Jul; 52(7):2168-78. PubMed ID: 15986348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Azathioprine for long-term maintenance of remission in autoimmune hepatitis.
    Johnson PJ; McFarlane IG; Williams R
    N Engl J Med; 1995 Oct; 333(15):958-63. PubMed ID: 7666914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis.
    van Denderen JC; van der Paardt M; Nurmohamed MT; de Ryck YM; Dijkmans BA; van der Horst-Bruinsma IE
    Ann Rheum Dis; 2005 Dec; 64(12):1761-4. PubMed ID: 15901634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experience with rituximab treatment (monoclonal antibodies to B-lymphocyte CD20 receptors) of Wegener's granulomatosis patients with renal impairment].
    Novikov PI; Krivosheev OG; Semenkova EN
    Ter Arkh; 2011; 83(11):70-6. PubMed ID: 22312891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial.
    Stone JH;
    Arthritis Rheum; 2003 Aug; 48(8):2299-309. PubMed ID: 12905485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjunctive anakinra in patients with active rheumatoid arthritis despite methotrexate, or leflunomide, or cyclosporin-A monotherapy: a 48-week, comparative, prospective study.
    Karanikolas G; Charalambopoulos D; Vaiopoulos G; Andrianakos A; Rapti A; Karras D; Kaskani E; Sfikakis PP
    Rheumatology (Oxford); 2008 Sep; 47(9):1384-8. PubMed ID: 18603660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients.
    Faurschou M; Sorensen IJ; Mellemkjaer L; Loft AG; Thomsen BS; Tvede N; Baslund B
    J Rheumatol; 2008 Jan; 35(1):100-5. PubMed ID: 17937462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leflunomide versus methotrexate in Wegener's granulomatosis.
    Jayne D
    Rheumatology (Oxford); 2007 Jul; 46(7):1047-8. PubMed ID: 17409129
    [No Abstract]   [Full Text] [Related]  

  • 37. Update on the treatment of Wegener's granulomatosis.
    Esper GJ; Johnson JS
    Bull Rheum Dis; 1999; 48(11):1-4. PubMed ID: 10721552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial.
    van Tuyl LH; Lems WF; Voskuyl AE; Kerstens PJ; Garnero P; Dijkmans BA; Boers M
    Ann Rheum Dis; 2008 Nov; 67(11):1574-7. PubMed ID: 18625629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can sulfasalazine therapy induce or exacerbate Wegener's granulomatosis?
    Denissen NH; Peters JG; Masereeuw R; Barrera P
    Scand J Rheumatol; 2008; 37(1):72-4. PubMed ID: 18189198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.